Tumour Stroma Ratio Assessment Using Digital Image Analysis Predicts Survival in Triple Negative and Luminal Breast Cancer.

Simple Summary: Tumour stroma is known to predict outcome and play an important role in the growth and spread of solid tumours and their response to therapy. In breast cancer, there is evidence that the tumour stroma ratio (TSR) can predict outcome in aggressive triple negative breast cancer, but it...

Descripción completa

Detalles Bibliográficos
Publicado en:Cancers Vol. 12; no. 12; pp. 3749 - 3750
Autores principales: Millar, Ewan KA, Browne, Lois H., Beretov, Julia, Lee, Kirsty, Lynch, Jodi, Swarbrick, Alexander, Graham, Peter H.
Formato: pictorial research tables/charts Journal Article
Publicado: MDPI Dec2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=148537863&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 148537863
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        20726694
        B74B
      jtl: Cancers
      issn: 20726694
      maglogo: N
    pubinfo:
      dt: Dec2020
      vid: 12
      iid: 12
      pid: 97109
      pub: MDPI
    artinfo:
      ui:
        148537863
        148537863
        148537863
        10.3390/cancers12123749
        148537863
      ppf: 3749
      ppct: 1
      formats:
      tig:
        atl: Tumour Stroma Ratio Assessment Using Digital Image Analysis Predicts Survival in Triple Negative and Luminal Breast Cancer.
      aug:
        au:
          Millar, Ewan KA
          Browne, Lois H.
          Beretov, Julia
          Lee, Kirsty
          Lynch, Jodi
          Swarbrick, Alexander
          Graham, Peter H.
        affil: Department of Anatomical Pathology, New South Wales Health Pathology, St George Hospital, Kogarah, NSW 2217, Australia
      sug:
        subj:
          Breast Neoplasms Prognosis
          Breast Neoplasms Pathology
          Tumor Burden Evaluation
          Digital Imaging
          Image Processing, Computer Assisted
          Machine Learning
          Algorithms
          Tumor Markers, Biological
          Human
          Female
          Cancer Patients
          Tissue Array Analysis
          Cox Proportional Hazards Model
          Kaplan-Meier Estimator
          Survival Analysis
          Confidence Intervals
          Descriptive Statistics
          Female
      ab: Simple Summary: Tumour stroma is known to predict outcome and play an important role in the growth and spread of solid tumours and their response to therapy. In breast cancer, there is evidence that the tumour stroma ratio (TSR) can predict outcome in aggressive triple negative breast cancer, but its value for the more common hormone receptor positive breast cancer is unclear. Using computerised image analysis and machine learning algorithms, we show that TSR is an important factor in predicting outcome for triple negative disease and hormone receptor positive cancer. However, its influence on good or poor outcome appears to depend on tumour type and the relative predominance of the stromal component. By better understanding the role of the tumour stroma in cancer growth, and its response to treatment, this study may help support the role of TSR as a new prognostic marker for breast cancer to guide clinical decision making. We aimed to determine the clinical significance of tumour stroma ratio (TSR) in luminal and triple negative breast cancer (TNBC) using digital image analysis and machine learning algorithms. Automated image analysis using QuPath software was applied to a cohort of 647 breast cancer patients (403 luminal and 244 TNBC) using digital H&E images of tissue microarrays (TMAs). Kaplan–Meier and Cox proportional hazards were used to ascertain relationships with overall survival (OS) and breast cancer specific survival (BCSS). For TNBC, low TSR (high stroma) was associated with poor prognosis for both OS (HR 1.9, CI 1.1–3.3, p = 0.021) and BCSS (HR 2.6, HR 1.3–5.4, p = 0.007) in multivariate models, independent of age, size, grade, sTILs, lymph nodal status and chemotherapy. However, for luminal tumours, low TSR (high stroma) was associated with a favourable prognosis in MVA for OS (HR 0.6, CI 0.4–0.8, p = 0.001) but not for BCSS. TSR is a prognostic factor of most significance in TNBC, but also in luminal breast cancer, and can be reliably assessed using quantitative image analysis of TMAs. Further investigation into the contribution of tumour subtype stromal phenotype may further refine these findings.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N